Lexeo Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 52.5% | 52.5% | -61.1% |
| FY2023 | -58.5% | -58.5% | -47.5% |
| FY2024 | -84.2% | -84.2% | -66.9% |
| FY2025 | -40.5% | -40.5% | -37.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 52.5% | 52.5% | -61.1% |
| FY2023 | -58.5% | -58.5% | -47.5% |
| FY2024 | -84.2% | -84.2% | -66.9% |
| FY2025 | -40.5% | -40.5% | -37.2% |